Madhav Menon | Mount Sinai

About Me

Dr. Menon joined the Department of Nephrology and the Recanati/Miller Transplantation Institute after pursuing an intensive research track. Dr. Menon completed fellowships in Nephrology as well as Transplant Nephrology at Mount Sinai. Dr. Menon has joined the faculty at Mount Sinai and currently runs a clinical practice in transplant and general Nephrology and remains active in research.

Dr. Menon's specific interests extend from his mentored research that are related to the application of genomics on chronic kidney allograft failure and kidney fibrosis. As a result of this research, Shroom3 has been identified as a gene whose expression precedes and correlates with allograft fibrosis.

Dr. Menon is also the site primary investigator (Site PI) for the CTOT-19 that seeks to study the impact of inhibiting early allograft inflammation on long term outcomes in kidney transplantation.

For a complete list of indexed published work:

http://www.ncbi.nlm.nih.gov/pubmed/?term=menon+mc

To learn more about kidney/pancreas transplantation at RMTI please visit:

www.mountsinaiRMTI.org

Language

English

Position

ADJUNCT ASSOCIATE PROFESSOR | Medicine, Nephrology

Research Topics

Fibrosis, Genomics, Kidney, Transplantation

About Me

Dr. Menon joined the Department of Nephrology and the Recanati/Miller Transplantation Institute after pursuing an intensive research track. Dr. Menon completed fellowships in Nephrology as well as Transplant Nephrology at Mount Sinai. Dr. Menon has joined the faculty at Mount Sinai and currently runs a clinical practice in transplant and general Nephrology and remains active in research.

Dr. Menon's specific interests extend from his mentored research that are related to the application of genomics on chronic kidney allograft failure and kidney fibrosis. As a result of this research, Shroom3 has been identified as a gene whose expression precedes and correlates with allograft fibrosis.

Dr. Menon is also the site primary investigator (Site PI) for the CTOT-19 that seeks to study the impact of inhibiting early allograft inflammation on long term outcomes in kidney transplantation.

For a complete list of indexed published work:

http://www.ncbi.nlm.nih.gov/pubmed/?term=menon+mc

To learn more about kidney/pancreas transplantation at RMTI please visit:

www.mountsinaiRMTI.org

Language

English

Position

ADJUNCT ASSOCIATE PROFESSOR | Medicine, Nephrology

Research Topics

Fibrosis, Genomics, Kidney, Transplantation

Clinical Focus

Acute Kidney Injury
Acute Renal Failure
Chronic Kidney Disease
End Stage Renal Disease
Kidney Biopsy
Kidney Disease (Acute Or Chronic)
Kidney Failure
Kidney Transplant
Kidney Transplant Care

Education

MD, PGIMER, Chandigarh

Awards

2019

Harold and Lamport Golden Clinical Research Award

Icahn School of Medicine at Mount Sinai

2017

New Investigator

AHA Council on Kidney and Cardiovascular disease

2016

Young investigator award

AHA Council on Kidney and Cardiovascular disease

2015

AHA Scientific Development Award

American Heart Association

2014

Young Investigator Award

World Transplant Congress, San Francisco

2013

Young Investigator Award

American Society of Transplantation/American Society of Transplant Surgeons, Seattle

2013

Outstanding Research Award

New York Society of Nephrology, New York

2012

ASN Research Fellowship

American Society of Nephrology

2010

Williams J Williams Award

State University of New York, Syracuse

2009

Best Graduating Resident Award

State University of New York, Syracuse

2006

Medal of the First Order, Best graduating resident

PGIMER Internal Medicine Residency Program

2001

Ashoka Medal

Department of Surgery, Calicut University, Calicut India

2000

Dr. T. K. Komalan Nair Memorial Award

Department of Social and Preventive Medicine, Calicut University, Calicut India

2000

Dr. Vasanthi Menon Memorial Award

Department of Community Medicine, Calicut Medical College, Calicut India

Publications

Madhav Menon, MD Profile on PlumX

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Menon during 2021 and/or 2022. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

Miscellaneous MedicoLegal

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.